TFA
ARQT icon

Toth Financial Advisory’s Arcutis Biotherapeutics ARQT Stock Holding History

Toth Financial Advisory’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$285K Buy
+10,770
New +$282K 0.03% 207
2021
Q4 		– Sell
-50
Closed -$1K – 752
2021
Q3 		$1K Hold
50
– – ﹤0.01% 695
2021
Q2 		$1K Buy
+50
New +$1.41K ﹤0.01% 636

Other funds holding ARQT

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Toth Financial Advisory's ARQT Position: Q3 2026 in Review

Toth Financial Advisory opened a new position in Arcutis Biotherapeutics (ARQT) in Q3 2026: 10,770 shares worth $285K. The stake represents 0.03% of the portfolio and ranks #207 among its holdings. This is a return to the name: Toth Financial Advisory previously reported a position in ARQT as recently as Q3 2021.

Toth Financial Advisory first reported a position in ARQT in Q2 2021 and has held it in 3 quarters since. 7 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • Toth Financial Advisory held 10,770 shares of Arcutis Biotherapeutics worth $285K as of Q3 2026.
  • Arcutis Biotherapeutics was a new Toth Financial Advisory position in Q3 2026.
  • Arcutis Biotherapeutics made up 0.03% of Toth Financial Advisory's portfolio in Q3 2026, its #207 holding.
  • Toth Financial Advisory first reported a position in Arcutis Biotherapeutics in Q2 2021 and has held it in 3 quarters since.
  • 7 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.